Erythrocyte‐Membrane‐Camouflaged Nanoplatform for Intravenous Glucose‐Responsive Insulin Delivery

Abstract

An artificial "closed-loop" system that mimics the glucose-responsive insulin secretion of pancreas β-cells can potentially improve the treatment efficacy for diabetes. Herein, a lipid bilayer-coated polymeric nanoparticle (NP) with "core-shell" structure is designed. As far as it is known, it is the first and only intravenous nanoplatform utilizing enzymatic-oxidation scheme to achieve glucose-responsive insulin delivery so far. Ethoxy acetal-derivatized dextran nanoparticles (Ace-DEX NPs) are constructed as "inner core" loaded with insulin, and coloading glucose oxidase (GOx) and catalase (CAT) endow the "inner core" excellent glucose-sensitive ability. Red blood cell membrane (RBCm)-derived coating is adopted as "outer shell." It collectively provides a closed microenvironment for GOx-based enzymatic-oxidation scheme and camouflages it from elimination. Above all, the anchored glucose transporters (GLUTs) on the "outer shell" are able to sense blood glucose levels and facilitate the transport of outer blood glucose getting inside. Under a hyperglycemic condition, the internalized glucose is catalytically converted into gluconic acid with the aid of the GOx and subsequently triggers acid degradation of the "inner core" to secrete insulin. By governing the blood glucose levels on an automatic and continuous basis, the RBCm-Ace-DEX NPs can effectively respond to hyperglycemia and turn to resting conditions under normoglycemia.

Erythrocyte Membrane Cloaked Curcumin-Loaded Nanoparticles for Enhanced Chemotherapy

“…Taken together, all these data allow us to conclude that the p-PLGA NPs were successfully coated with a RBCM layer. The observations noted here are in line with those in the literature [13,14].…”

Artificial Platelets for Efficient siRNA Delivery to Clear “Bad Cholesterol”

“…Importantly, the platelet membrane-camouflaged nanoparticles had prolonged circulation time by approximately 2-fold compared with the bare nanoparticles. Red blood cells (RBCs)-mimetic nanoparticles have also been extensively studied and this style of nanoparticles shows mimetic properties of mechanical, prolonged circulation, and good biocompatibility . Although the coating with different blood cell-derived membranes, including the PM, RBCM, and PM-RBCM hybrid membrane, displayed similar organ-level localization (mostly in the liver and spleen), our experiment revealed that PM-camouflaged nanoparticles induced more efficient cellular uptake compared with RBC membrane-treated nanoparticles (RPDP) with a similar size (Figure S7 and Figure S8) which highlights the applicability of PMs for camouflage in liver delivery.…”

Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment

“…PLGA-TCA/DLPC/HCQ was prepared by double-emulsion based solvent evaporation method ( Fig. 1 B) 34 , 35 . With the addition of HCQ into PLGA-TCA/DLPC NPs, the particle size increased from ∼176 to ∼210 nm ( Fig.…”